source
- FDA issues warning letters to two Chinese API makers for refusing record requestsThe U.S. Food and Drug Administration sent warning letters to Chongqing Qiancan Technology and Tianjin Healthcare Medical Technology after both companies declined to provide records the agency requ…
- Capricor trims 10% of workforce as FDA decision on Duchenne cell therapy approachesCapricor Therapeutics announced it is cutting about 10% of its staff ahead of an upcoming FDA decision on its Duchenne muscular dystrophy cell therapy, deramiocel. The biotech said it had 231 full…